Last week, Gavi, the Vaccine Alliance, completed a $7.5 billion replenishment to fund its work on immunization in the world’s poorest countries between now and 2020. Gavi’s next step is to ensure that the money is used as effectively as possible to save lives and improve health.
CGD Policy Blogs
As African leaders meet in Washington this week, one issue is not on the agenda: the poor quality of basic economic and social data in the region.
Since the term “data revolution” was brandished in the High-Level Panel report on the Post-2015 Development Agenda, there has been a flurry of activity to define, develop, and drive an agenda to transform the way development statistics are collected, used, and shared the world over. And this makes sense — assessing the new development agenda, regardless of its details, will need accurate data.
Afghanistan accounted for 15 percent of all U.S. economic assistance allocated in FY2012, amounting to 2 billion dollars. USAID has contributed at least 15 billion in aid to Afghanistan since 2001, with cumulative investments in the health sector at nearly 1 billion. But the impact of these investments has been difficult to judge because of lack of reliable data and accurate measurement, leaving many wondering: What have these funds achieved? In particular, has this economic assistance improved the health of Afghans?